期刊文献+

胃肠道间质细胞瘤16例诊断与治疗分析

下载PDF
导出
摘要 目的探讨胃肠道间质细胞瘤的诊断与治疗。方法分析16例胃肠道间质细胞瘤临床资料,16例均经手术后病理确诊。结果患者以腹胀、腹部不适、腹痛、消化道出血为主要临床症状,肿瘤多发生于胃、小肠。结论内镜、影像学和免疫组织学结合检查是确诊胃肠间质细胞瘤的方法,手术彻底切除是治疗的关键。
出处 《苏州大学学报(医学版)》 CAS 北大核心 2008年第3期495-496,共2页 Suzhou University Journal of Medical Science
  • 相关文献

参考文献7

  • 1Mazur MT, Clark HB. Gastric stromal tumors[J]. Am J Surg Pathol, 1983,7(6):507-519.
  • 2Singer S,Rubin BP,Lux ML,et al. Pmgnosic value of kit mulation type,mltotic activity,and histologic stub type in gastrointestinal stromal tumors[J]. J Clin Oncol, 2002,20 (18):3898-3905.
  • 3Fusaroli P,Caletti G. Endoscopic ultrasonography:current clinical role[J]. Eur J Gasttroenterol Hepatol, 2005, 17 (13):293-301.
  • 4Hirota S,Isozaki K,Moriyama Y,et al. Gain-of-funCtion mutations of c-kit in human gastrointestinal stromal tumors[J]. Selence, 1998,279(5350):577-580.
  • 5Heinrich MC,Corless CL, Duensing A,et al. PDGFRA activating mutations in gastrointestinal stromal tumors[J]. Science, 2003,299(5607):708-710.
  • 6Oensun H. Treatment of inoperable gastrointestinal stromal tumors with imatinib (Gleevc)[J]. Med Kin,2002,97 (Suppl 1):28-30.
  • 7詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85

二级参考文献21

  • 1Mudan SS,Conlon KC,Woodruff J,et al.Salvage surgery in recurrent gastrointestinal sarcoma:prognostic factors to guide patient selection.Cancer,2000,88:66-74.
  • 2DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival.Ann Surg,2000,231:51-58.
  • 3Mocellin S,Mencarelli R,Foletto M,et al.Gastrointestinal stromal tumors:from a surgical to a molecular approach.Int J Cancer,2003,107:171-176.
  • 4Dematteo RP,Shah A,Fong Y,et al.Results of hepatic resection for sarcoma metastatic to liver.Ann Surg,2001,234:540-548.
  • 5Husted TL,Neff G,Thomas MJ,et al.Liver transplantation for primary or metastatic sarcoma to the liver.Am J Transplant,2006,6:392-397.
  • 6Blanke CD,Demetri GD,Von Mehren M,et al.kong-term follow-up of a phase Ⅱ randomized trial in advanced gastrointestinal stromal tumor (GIST) patients treated with imatinib mesylate.Abstract No:9528,J Clin Oncol,2006 ASCO Annual Meeting Proceedings Part Ⅰ.Vol 24,No.18S.
  • 7Perez EA,Livingstone AS,Franceschi D,et al.Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.J Am Coll Surg,2006,202:623-629.
  • 8Goettsch WG,Bos SD,Broekveldt-Postma N,et al.Incidence of gastrointestinal stromal tumours is underestimated:results of a nation-wide study.Eur J Cancer,2005,41:2868-2872.
  • 9Miettinen M,Lasota J.Gastrointestinal stromal tumours-definition,clinical,histological,immunohistochemical,and molecular genetic features and differential diagnosis.Virchows Arch,2001,438:1-12.
  • 10Demetri GD,von Mehren M,Blanke CD,et al.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours.N Engl J Med,2002,347:472-480.

共引文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部